Advances in immunotyping of colorectal cancer

Immunotherapy has transformed treatment for various types of malignancy. However, the benefit of immunotherapy is limited to a minority of patients with mismatch-repair-deficient (dMMR) and microsatellite instability-high (MSI-H) (dMMR-MSI-H) colorectal cancer (CRC). Understanding the complexity and...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 14; p. 1259461
Main Authors Wu, Yinhang, Zhuang, Jing, Qu, Zhanbo, Yang, Xi, Han, Shuwen
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 09.10.2023
Subjects
Online AccessGet full text

Cover

Loading…